General MedicationsINJECTIONStandard
PAMIDRONATE DISODIUM
PAMIDRONATE DISODIUM
Standard Dose
60MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 077433 (ANDA).
Marketing status: Prescription Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 60MG/VIAL Sponsor AREVA PHARMS Submission history Latest submission status date: 2016-11-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 077433 (ANDA). Marketing status: Prescription Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 60MG/VIAL Sponsor AREVA PHARMS Submission history Latest submission status date: 2016-11-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.